Blog
RSS FeedPosted by Michael Wonder on 30 Aug 2018
Woman's desperate plea to PHARMAC to fund $6,000/month cancer drug
31 august 2018 - A New Zealand woman is pleading with pharmaceutical giant PHARMAC and MPs to fund an expensive ...
Posted by Michael Wonder on 30 Aug 2018
Renflexis (infliximab for injection) added to British Columbia's Provincial Drug Plan for all approved indications
22 August 2018 - Renflexis has been added to drug formulary for the treatment of adult and paediatric Crohn's disease and ...
Posted by Michael Wonder on 30 Aug 2018
So the Government has agreed to reduce the time from PBAC recommendation to PBS listing by two months
30 August 2018 - How will this new objective be assessed? ...
Posted by Michael Wonder on 30 Aug 2018
Proposal to list sapropterin for use in pregnancy by women with phenylketonuria
30 August 2018 - PHARMAC is seeking feedback on a proposal to fund sapropterin tablets, a treatment for the rare ...
Posted by Michael Wonder on 29 Aug 2018
Cancer charities dismayed after ‘new generation’ therapy rejected as too expensive
29 August 2018 - A NICE committee said the cost of the drug was “too high for it to be considered ...
Posted by Michael Wonder on 29 Aug 2018
Patients being bled by specialists as out-of-pocket costs surge
30 August 2018 - Health insurance giant Medibank has warned that one in eight of its customers is being forced ...
Posted by Michael Wonder on 29 Aug 2018
Life-changing drug Spinraza for spinal muscular atrophy patients costing adults at least $500,000
29 August 2018 - In a small lounge in Essendon, with his parents by his side, Chris Kessaris sat in ...
Posted by Michael Wonder on 29 Aug 2018
B.C. to sue opioid makers for health care expenses of overdose crisis
29 August 2018 - The British Columbia Government will sue opioid manufacturers including Purdue Pharma in an effort to recoup ...
Posted by Michael Wonder on 29 Aug 2018
Developing tools to support digital health and medtech innovation
8 August 2018 - NICE is involved in two key initiatives with national partners to achieve these aims by developing standards ...
Posted by Michael Wonder on 29 Aug 2018
Proposal to move to one funded brand of lamotrigine (Logem)
29 August 2018 - PHARMAC is seeking feedback on a proposed change to the funding of lamotrigine dispersible tablets used ...
Posted by Michael Wonder on 28 Aug 2018
Ottawa’s drug-pricing changes threaten Canadians who suffer from rare diseases
28 August 2018 - The federal government’s plan to increasingly regulate the costs of pharmaceuticals could mean Canadians with cystic ...
Posted by Michael Wonder on 28 Aug 2018
Cabometyx gets NICE recommendation in renal cell carcinoma
24 August 2018 - French drugmaker Ipsen that it has received a recommendation from NICE for National Health Service funding ...
Posted by Michael Wonder on 28 Aug 2018
Feedback encouraged to allow use of life extending treatment on NHS for those with blood cancer
28 August 2018 - CAR-T considered to be an exciting innovation which can cure some patients but very expensive. ...
Posted by Michael Wonder on 28 Aug 2018
NICE says ‘no’ to Gilead's Yescarta in draft guidelines
28 August 2018 - NHS funding for Gilead’s freshly approved CAR-T therapy Yescarta has been turned down in draft guidelines ...
Posted by Michael Wonder on 27 Aug 2018
Bupa blunder: health insurer pays price for restricting hospital options
27 August 2018 - The biggest health insurer in Australia, Bupa, has admitted the controversial changes it made to paying ...